CONTEXT: Persons with spinal cord injury or disorder (SCI/D) are at increased risk for antibiotic resistance because of recurrent infections and subsequent use of antibiotics. However, there are no studies focused on providers who care for these patients and their perceptions regarding antibiotic use and resistance. OBJECTIVE: To characterize SCI/D provider behavior and attitudes about antibiotic prescribing and resistance. DESIGN/ METHODS: Anonymous internet-based, cross-sectional survey. PARTICIPANTS: A total of 314 SCI/D clinicians who prescribe antibiotics (physicians, physician assistants, and nurse practitioners). RESULTS: A total of 118 providers responded (37.6% response rate) including 80 physicians, 20 nurse practitioners, and 18 physician assistants. The majority of respondents agreed with statements regarding the societal impact of antibiotic resistance; only 17.8% agreed that they prescribed antibiotics more than they should, but 61.0% agreed that patient demand was a major reason for prescribing unnecessary antibiotics. The most frequent problematic organisms reported were: methicillin-resistant Staphylococcus aureus (83.1%), multidrug-resistant Pseudomonas (61.0%), and Clostridium difficile (57.6%). The most frequent antibiotics selected for outpatient treatment of community-acquired pneumonia treatment, based on a clinical scenario were azithromycin (36.4%) and respiratory fluoroquinolones (22.9%). CONCLUSION: These data show that the respondents are aware of and concerned with the problem of antibiotic resistance in their practice. Clinician respondents also endorsed the need to improve their own knowledge and that of their colleagues regarding appropriate antibiotic prescribing. These findings suggest that interventions should focus on provider education, particularly regarding appropriate antibiotic prescribing.
CONTEXT: Persons with spinal cord injury or disorder (SCI/D) are at increased risk for antibiotic resistance because of recurrent infections and subsequent use of antibiotics. However, there are no studies focused on providers who care for these patients and their perceptions regarding antibiotic use and resistance. OBJECTIVE: To characterize SCI/D provider behavior and attitudes about antibiotic prescribing and resistance. DESIGN/ METHODS: Anonymous internet-based, cross-sectional survey. PARTICIPANTS: A total of 314 SCI/D clinicians who prescribe antibiotics (physicians, physician assistants, and nurse practitioners). RESULTS: A total of 118 providers responded (37.6% response rate) including 80 physicians, 20 nurse practitioners, and 18 physician assistants. The majority of respondents agreed with statements regarding the societal impact of antibiotic resistance; only 17.8% agreed that they prescribed antibiotics more than they should, but 61.0% agreed that patient demand was a major reason for prescribing unnecessary antibiotics. The most frequent problematic organisms reported were: methicillin-resistant Staphylococcus aureus (83.1%), multidrug-resistant Pseudomonas (61.0%), and Clostridium difficile (57.6%). The most frequent antibiotics selected for outpatient treatment of community-acquired pneumonia treatment, based on a clinical scenario were azithromycin (36.4%) and respiratory fluoroquinolones (22.9%). CONCLUSION: These data show that the respondents are aware of and concerned with the problem of antibiotic resistance in their practice. Clinician respondents also endorsed the need to improve their own knowledge and that of their colleagues regarding appropriate antibiotic prescribing. These findings suggest that interventions should focus on provider education, particularly regarding appropriate antibiotic prescribing.
Authors: C William Wester; Lakshmi Durairaj; Arthur T Evans; David N Schwartz; Shahid Husain; Enrique Martinez Journal: Arch Intern Med Date: 2002-10-28
Authors: Tara Bridget Giblin; Ronda L Sinkowitz-Cochran; Patricia L Harris; Sharon Jacobs; Kathy Liberatore; Marsha A Palfreyman; Edward I Harrison; Denise M Cardo Journal: Arch Intern Med Date: 2004 Aug 9-23
Authors: Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton Journal: Clin Infect Dis Date: 2006-12-13 Impact factor: 9.079
Authors: L Clifford McDonald; George E Killgore; Angela Thompson; Robert C Owens; Sophia V Kazakova; Susan P Sambol; Stuart Johnson; Dale N Gerding Journal: N Engl J Med Date: 2005-12-01 Impact factor: 91.245
Authors: Charlesnika T Evans; Sherri L LaVela; Frances M Weaver; Michael Priebe; Paul Sandford; Pamela Niemiec; Scott Miskevics; Jorge P Parada Journal: Infect Control Hosp Epidemiol Date: 2008-03 Impact factor: 3.254
Authors: Lionel A Mandell; John G Bartlett; Scott F Dowell; Thomas M File; Daniel M Musher; Cynthia Whitney Journal: Clin Infect Dis Date: 2003-11-03 Impact factor: 9.079
Authors: Rachel M Zetts; Andrea M Garcia; Jason N Doctor; Jeffrey S Gerber; Jeffrey A Linder; David Y Hyun Journal: Open Forum Infect Dis Date: 2020-06-20 Impact factor: 3.835
Authors: Juyan Julia Zhou; Sameer J Patel; Haomiao Jia; Scott A Weisenberg; E Yoko Furuya; Christine J Kubin; Luis Alba; Kyu Rhee; Lisa Saiman Journal: Infect Control Hosp Epidemiol Date: 2013-01-24 Impact factor: 3.254
Authors: Charlesnika T Evans; Thea J Rogers; Amy Chin; Stuart Johnson; Bridget Smith; Frances M Weaver; Stephen P Burns Journal: J Spinal Cord Med Date: 2013-09 Impact factor: 1.985
Authors: Rachel M Zetts; Andrea Stoesz; Andrea M Garcia; Jason N Doctor; Jeffrey S Gerber; Jeffrey A Linder; David Y Hyun Journal: BMJ Open Date: 2020-07-14 Impact factor: 2.692
Authors: Bei Zhang; Timothy J Kopper; Xiaodong Liu; Zheng Cui; Steven G Van Lanen; John C Gensel Journal: CNS Neurosci Ther Date: 2019-01-24 Impact factor: 5.243
Authors: Bei Zhang; William M Bailey; Timothy J Kopper; Michael B Orr; David J Feola; John C Gensel Journal: J Neuroinflammation Date: 2015-11-24 Impact factor: 8.322